July Smoking harms nearly every organ of the body, causing many diseases and reducing quality of life and life expectancy (1). This report assesses the health consequences and productivity losses attributable to smoking in the United States during [1997][1998][1999][2000][2001]. CDC calculated national estimates of annual smokingattributable mortality (SAM), years of potential life lost (YPLL) for adults and infants, and productivity losses for adults. The findings indicated that, during 1997-2001, cigarette smoking and exposure to tobacco smoke resulted in approximately 438,000 premature deaths in the United States, 5.5 million YPLL, and $92 billion in productivity losses annually. Implementation of comprehensive tobacco-control programs as recommended by CDC can reduce smoking prevalence and related mortality and health-care costs (1).
Smoking harms nearly every organ of the body, causing many diseases and reducing quality of life and life expectancy (1) . This report assesses the health consequences and productivity losses attributable to smoking in the United States during [1997] [1998] [1999] [2000] [2001] . CDC calculated national estimates of annual smokingattributable mortality (SAM), years of potential life lost (YPLL) for adults and infants, and productivity losses for adults. The findings indicated that, during 1997-2001, cigarette smoking and exposure to tobacco smoke resulted in approximately 438,000 premature deaths in the United States, 5.5 million YPLL, and $92 billion in productivity losses annually. Implementation of comprehensive tobacco-control programs as recommended by CDC can reduce smoking prevalence and related mortality and health-care costs (1) .
The Adult and Maternal and Child Health SmokingAttributable Mortality, Morbidity and Economic Cost (SAMMEC) software (2) was revised on the basis of findings from the 2004 Surgeon General's report on diseases caused by smoking (1) . The list of smoking-attributable diseases now includes stomach cancer and acute myeloid leukemia and excludes hypertension. Sex-and age-specific smokingattributable deaths were calculated by multiplying the total number of deaths for 19 adult and four infant disease categories by estimates of the smoking-attributable fraction (SAF) of preventable deaths. The attributable fractions provide estimates of the public health burden of each risk factor and the relative importance of risk factors for multifactorial diseases. Because of the effect of interactions between various risk factors, attributable fractions for a given disease can add up to more than 100%. For adults, SAFs were derived by using sexspecific relative risk (RR) estimates (2) for current and former smokers for each cause of death from the American Cancer Society's Cancer Prevention Study-II (CPS-II) for the period 1982-1988 (2) . For ischemic heart disease and cerebrovascular disease deaths, RR estimates were also stratified by age (35-64 years and >65 years). SAFs also used sex-and agespecific (35-64 years and >65 years) current and former cigarette smoking-prevalence estimates from the National Health Interview Survey.* For infants, SAFs were calculated by using pediatric RR estimates (2) and maternal smoking prevalence estimates from birth certificates (2) . Smoking-attributable YPLL and productivity losses were estimated by multiplying sex-and age-specific SAM by remaining life expectancy (3) and lifetime earnings data (4) . In addition, smoking-attributable fire-related deaths (5) and lung cancer and heart disease deaths attributable to exposure to secondhand smoke (6, 7) were included in the SAM estimates.
During 1997-2001, smoking resulted in an estimated annual average of 259,494 deaths among men and 178,408 deaths among women in the United States (Table) . Among adults, 158,529 (39.8%) of these deaths were attributed to cancer, 137,979 (34.7%) to cardiovascular diseases, and 101,454 (25.5%) to respiratory diseases. The three leading specific causes of smoking-attributable death were lung * SAFs for each disease are calculated by using the following equation: SAF = [(p 1 (RR 1 -1) + p 2 (RR 2 -1)] / [ p 1 (RR 1 -1) + p 2 (RR 2 -1) + 1] where p 1 = percentage of current smokers (persons who have smoked >100 cigarettes and now smoke every day or some days), p 2 = percentage of former smokers (persons who have smoked >100 cigarettes and do not currently smoke), RR 1 = relative risk for current smokers relative to never smokers, and RR 2 = relative risk for former smokers relative to never smokers.
Malignant neoplasms
Lip, oral cavity, pharynx (C00-C14) 4 Hyperthermia is the elevation of body temperature resulting from the body's inability to dissipate heat (1) . Continued exposure to ambient heat close to body temperature (98.6 º F [37.0 º C]) contributes to a substantial number of deaths from hyperthermia, especially among elderly persons (2) . To assess the health risk from hyperthermia, Arizona health practitioners and CDC researched cases of heat-related death and illness in Arizona, used U.S. death certificate data to summarize trends in heat-related deaths, and compared agespecific, heat-related death rates in Arizona with those in the United States overall. Findings indicated that, during 1979-2002, a total of 4,780 heat-related deaths in the United States were attributable to weather conditions and that, during 1993-2002, the incidence of such deaths was three to seven times greater in Arizona than in the United States overall. Public health agencies in communities affected by periods of extreme heat should educate populations at risk (e.g., persons aged >65 years) and consider designing and implementing locationspecific heat response plans (HRPs).
Case Reports -Arizona Case 1. In July 2001, a boy aged 14 years was participating in a youth boot camp west of Phoenix when he began hallucinating and eating dirt. He had been in direct sunlight for 1-5 hours in an outside temperature of 111 º F (44 º C). When the boy became unresponsive, camp supervisors placed him in a bathtub with a running shower. The tub drain reportedly became blocked with dirt and other material. The camp supervisors returned to find the boy with his face in the water. The supervisors telephoned 911, but the boy never regained consciousness and was pronounced dead later that night. The office of the medical examiner (ME) attributed the boy's death to complications of near-drowning and dehydration from heat exposure. The ME did not document a core body temperature. Case 2. In August 2004, at 5:50 p.m, two sisters aged 2 and 4 years were found unresponsive in the locked family car by their mother in a Phoenix suburb. The children had been locked in the car for more than 15 minutes. Temperatures inside and outside the automobile were not recorded; however, high temperatures in the area on that day and at that time ranged from the mid-90s (~32 º C) to 101 º F (38 º C). When emergency medical services (EMS) personnel arrived, both children were asystolic. During helicopter transport to the hospital, EMS personnel administered multiple doses of intraosseous epinephrine and atropine. At the emergency department (ED), rectal temperatures were 106.4 º F (41.3 º C) for the younger girl and 105.0 º F (40.6 º C) for the older girl. Both children were pronounced dead within 10 minutes of arrival at the ED. The ME found severe cerebral edema in both children and declared hyperthermia as the cause of death.
Case 3. In May 2004, at approximately 4 p.m. in Phoenix, a man aged 35 years with a history of schizophrenia suddenly collapsed after working in a garden for 1 hour in 98 º F (37 º C) heat. EMS personnel found him unresponsive, with a heart rate of 170 beats per minute (bpm). At the ED, his rectal temperature was 105.4 º F (40.8 º C). Primary diagnosis was heat stroke with nonepileptic convulsions, with a secondary diagnosis of burn blisters with epidermal loss on limbs and trunk. The patient was intubated, rapidly cooled with fans and ice baths, and started on ceftriaxone and vancomycin; however, subsequent cultures and imaging studies were within normal limits. The man's hospital course was complicated by rhabdomyolysis, but he recovered and was discharged on the third day. Case 4. In September 2004, at approximately 11 a.m. in a Phoenix suburb, a woman aged 59 years who had been riding her bicycle was found lying on the ground with altered mental status. The ambient temperature was 95 º F (35 º C). EMS personnel recorded a blood pressure of 130/72 mm/Hg, a heart rate of 174 bpm, and a respiratory rate of 28 breaths per minute. Serial examinations, multiple radiographs, and computerized tomography scans did not locate any trauma. The patient had an oral temperature of 101.4 º F (38.8 º C) 1 hour after arriving at the ED. Primary diagnosis was heat stroke; schizophrenia (not otherwise specified), gastric hemorrhage, and acute renal failure were secondary diagnoses. The woman's mental status returned to baseline when she was externally cooled with water misters and fans. She was observed overnight and discharged the next day after improvement of her clinical status.
Heat-Related Mortality -United States, 1979-2002
During 1979-2002, the most recent years for which national data are available, 4,780 deaths were classified as heat related because of weather conditions.* Of the 4,686 (98%) heat-related deaths attributed to weather for which age of the decedent was reported, 260 (6%) occurred among children aged <15 years, 2,356 (50%) among persons aged 15-64 years, and 2,070 (44%) among persons aged >65 years (3). During 1979-2002, heat waves with high mortality occurred in 1980 (St. Louis and Kansas City, Missouri), 1995 (Chicago, Illinois), and 1999 (Cincinnati, Ohio, and Chicago). During that period, the annual rate of heat-related deaths from weather conditions was highest among persons aged >65 years ( Figure 1 ).
Heat-Related Mortality -Arizona, 1993-2002
Arizona experiences intense and prolonged summer heat. Normal daily maximum temperature reaches >100 º F (>38 º C) in early June and can remain at that level until mid-September (4). During 1993-2002, a total of 253 deaths in Arizona were attributable to heat exposure. During this period, Arizona had the highest average annual age-adjusted † rate of death from heat exposure (five deaths per million) among U.S. states. Within the state, the highest average annual age-adjusted death rates (>10 per million population) occurred in the western counties of Mohave, La Paz, and Yuma. Combining data from the period 1993-2002, the rate of death from heat exposure in Arizona for persons aged >25 years was three to seven times higher than that for the United States overall and ranged from two deaths per million persons aged 25-34 years to 42 deaths per million persons aged >85 years ( Figure 2 ). (5, 7, 8) . If unrecognized and untreated, these mild to moderate signs and symptoms can progress to heat stroke (6), a severe illness clinically defined as core body temperature >105.0 º F (>40.6 º C), accompanied by hot, dry skin and central nervous system abnormalities, such as delirium, convulsions, or coma (5, 7, 8) .
To prevent heat-related illness and death, public health agencies should identify susceptible populations and risk behaviors. Children, elderly persons, and persons without access to air conditioning are at increased risk for heat-related illness and death. In addition, persons with chronic mental disorders or cardiopulmonary disease and those receiving medications that interfere with salt and water balance, such as diuretics, anticholergic agents, and tranquilizers that impair sweating, are at greater risk for heat-related illness and death. Drinking alcoholic beverages, ingesting illicit drugs (e.g., cocaine or amphetamines), and participating in strenuous outdoor physical activities (e.g., sports or manual labor) in hot weather also are risk behaviors associated with heat-related illness (7, 9, 10) .
Periodic heat waves highlight the need for public health interventions to prevent excess morbidity and mortality; written HRPs are central to those interventions. HRPs detail actions that local government agencies and nongovernment organizations can take in the event of a forecast of extremely hot weather to reduce heat-related mortality (Box).
All heat-related deaths and illnesses are preventable. In hot weather, persons can take precautions, including rescheduling strenuous outdoor activities to cooler times of the day, reducing the level of physical activity, drinking additional water, wearing lightweight and light-colored clothing, and increasing the amount of time spent in air-conditioned environments (7). Indoors, persons can prevent sunlight from coming through windows and minimize cooking; sprinkling water on clothing also can reduce heat stress. Parents should never leave young children in parked cars and should keep cars locked when not in use. Relatives, neighbors, and caretakers of persons at risk for heat-related illness and death (e.g., elderly, disabled, and homebound persons) should frequently check on these persons, recognize symptoms of heat-related morbidity, and take appropriate action (5).
BOX. Criteria for development of an effective heat response plan (HRP)
• Identify a lead agency and other participating agencies and nongovernment organizations, describing roles and responsibilities in detail.
• Review plans annually, before onset of warm weather, to review response protocols and confirm participation of lead personnel.
• Identify activation and deactivation thresholds for the HRP by using community-specific factors affecting mortality (e.g., extremes in daytime high and nighttime low temperatures and deviation from local norms).
• Before a heat emergency, use preexisting communication plans and public education tools to define a clear communications strategy and pathway from the lead agency to first responders, the public, and the media.
• Define risk factors, populations at high risk, and methods to reach them (e.g., daily checks on the elderly by social service agency personnel and provision for transportation to air-conditioned public centers).
• Establish a method to evaluate and revise the HRP, including post-emergency meetings with participating agencies to review response activities, activation and deactivation thresholds, communication plans, outreach activities, and the association between weather data and heat-related morbidity and mortality. 
United States Influenza Activity
Influenza activity occurred at low levels from October to mid-December, steadily increased during January, and peaked in mid-February. Influenza A (H3N2) viruses predominated overall, but influenza B viruses were more frequently identified than influenza A viruses during late March through May. A small number of A (H1) viruses were also identified. 
Viral Surveillance

Influenza-Associated Pediatric Hospitalizations
Laboratory-confirmed, influenza-associated, pediatric hospitalizations are monitored in two population-based surveillance networks: the Emerging Infections Program (EIP) and the New Vaccine Surveillance Network (NVSN). During October 1, 2004-April 30, 2005,** the preliminary influenzaassociated hospitalization rates for children aged 0-4 years reported by NVSN and EIP were 7.0 and 3.1 per 10,000, respectively. EIP also monitors hospitalizations in children aged 5-17 years; the preliminary influenza-associated hospitalization rate for this age group was 0.6 per 10,000. The overall hospitalization rate reported by EIP for children aged 0-17 years was 1.3 per 10,000.
During 
Influenza-Associated Pediatric Mortality
In October 2004, pediatric deaths (i.e., deaths in children aged <18 years) associated with laboratory-confirmed influenza infection became a nationally notifiable condition. For the 2004-05 influenza season, 36 pediatric deaths have been reported to CDC from 16 states (California, Colorado, Florida, Georgia, Iowa, Maine, Maryland, Massachusetts, Michigan, Mississippi, Nevada, New Jersey, New York, Ohio, Pennsylvania, and Vermont) and New York City; all deaths were reported during January-June 2005. † Defined as temperature of >100.0 º F (>37.8 º C) and either cough or sore throat in the absence of a known cause other than influenza. § The national baseline was calculated as the mean percentage of patient visits for ILI during non-influenza weeks plus two standard deviations. Wide variability in regional data precludes calculating region-specific baselines and makes it inappropriate to apply the national baseline to regional data. National and regional percentages of patient visits for ILI are weighted on the basis of state population. ¶ Levels of activity are 1) no activity; 2) sporadic: isolated laboratory-confirmed influenza cases or laboratory-confirmed outbreak in one institution, with no increase in activity; 3) local: increased ILI in one region, or at least two institutional outbreaks (ILI or laboratory-confirmed influenza) in one region; virus activity no greater than sporadic in other regions; 4) regional: increased ILI activity or outbreaks (ILI or laboratory-confirmed influenza) in at least two but fewer than half of the regions in the state; and 5) widespread: increased ILI activity or outbreaks (ILI or laboratory-confirmed influenza) in at least half the regions in the state. ** Active prospective surveillance in EIP and NVSN for the 2004-05 influenza season ended as of April 30, 2005. † † NVSN provides population-based estimates of laboratory-confirmed influenza hospitalization rates in children aged <5 years admitted to NVSN hospitals with fever or respiratory symptoms. Children are prospectively enrolled, and respiratory samples are collected and tested by viral culture and reverse transcriptase-polymerase chain reaction (PCR). EIP conducts surveillance for laboratory-confirmed, influenza-related hospitalizations in person aged <18 years. Hospital laboratory and admission databases and infection-control logs are reviewed to identify children with a positive influenza test result (i.e., culture, direct or indirect fluorescent antibody assays, PCR, or a rapid test) from testing conducted as a part of their routine care. § § The expected seasonal baseline proportion of P&I deaths reported by the 122 Cities Mortality Reporting System is projected by using a robust regression procedure in which a periodic regression model is applied to the observed percentage of deaths from P&I during the previous 5 years. The epidemic threshold is 1.654 standard deviations above the seasonal baseline.
Worldwide Influenza Activity
During October 2004-May 2005, influenza A viruses circulated widely worldwide. Influenza A (H3N2) viruses predominated in most countries, whereas influenza A (H1) and B viruses circulated at low levels in most parts of the world. Influenza A (H3N2) viruses predominated and were associated with outbreaks in Asia (Hong Kong, Indonesia, Israel, and South Korea), Europe (Belgium, Finland, France, Germany, Italy, Latvia, Norway, Portugal, Romania, the Russian Federation, Spain, Sweden, Switzerland, Turkey, Ukraine, and the United Kingdom), and North America (Canada). Influenza A (H3N2) viruses also were reported in Africa (Egypt, Madagascar, Morocco, Senegal, South Africa, and Tunisia), Asia (China, India, Iraq, Iran, Japan, Kyrgyzstan, Malaysia, the Philippines, Singapore, Taiwan, and Thailand), Europe (Austria, Belarus, Bulgaria, Czech Republic, Denmark, Greece, Hungary, Iceland, Ireland, the Netherlands, Poland, Serbia and Montenegro, and Slovenia), South America and the Caribbean (Argentina, Brazil, Chile, Dominica, Guyana, Peru, Saint Lucia, and Venezuela), North America (Canada and Mexico), and Oceania (Australia, Guam, New Caledonia, and New Zealand).
Influenza A (H1) viruses circulated at low levels in most parts of the world. Influenza A (H1) viruses were isolated in Africa (Senegal, South Africa, and Tunisia), Asia (China, Hong Kong, Indonesia, Iran, Israel, Japan, Kazakhstan, Kyrgyzstan, Malaysia, Singapore, South Korea, Taiwan, and Thailand), Europe (Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Ireland, Italy, Latvia, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Sweden, Switzerland, Turkey, Ukraine, and the United Kingdom), and South America (Brazil and Peru).
Influenza Editorial Note: During the 2004-05 influenza season, influenza A (H3N2) viruses predominated in most countries in Asia, Europe, and North America, but influenza A (H1) and B viruses were also identified. In the United States, influenza activity peaked in February and was less severe than during the previous season. This program is intended for physicians, nurses, nurse practitioners, physician assistants, pharmacists, residents, medical and nursing students, and their colleagues who either administer vaccinations or set policy in the workplace. Anticipated topics include recommendations for influenza vaccination and an update of the influenza vaccine supply, meningococcal conjugate vaccine, acellular pertussis vaccine for adolescents, and revised varicella vaccination recommendations. Continuing education credit (2.5 hours of instruction) will be offered for various professions.
The program can be viewed via live webcast and will also be available for viewing for 30 days after the broadcast at http:// www.phppo.cdc.gov/phtn/webcast/immup2005. Information about the satellite broadcast, webcast, and continuing education registration is available at http://www.phppo.cdc.gov/ phtn/immup2005/default.asp. Information on locations for viewing the satellite broadcast can be obtained from state distance-learning coordinators (http://www.cdc.gov/nip/ed/ coordinators.htm). 25  12  2  1  --117  186  732  488  Calif.  39  46  ----994  841  14,736  13,842  Alaska  6  1  ----35  29  252  306  Hawaii  3  3  ----33  42  408 657 -8  3  Tex.  10  3  ------10  3   MOUNTAIN  59  40  2  1  5  4  --52  35  Mont. - PACIFIC  160  194  1  2  5  4  --154  188  Wash.  29  16  1  2  4  4  --24  10  Oreg.  25  38  ------25  38  Calif.  99  133  ------99  133  Alaska  1 
